欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/0779/003
药品名称Esmocard Lyo
活性成分
    • esmolol hydrochloride 2500.0 mg
剂型Powder for solution for infusion
上市许可持有人Orpha-Devel Handels und Vertrebs GmbH Wintergasse 85/1B, A-3299 Purkersdorf Austria
参考成员国 - 产品名称Netherlands (NL)
Esmocard Lyo
互认成员国 - 产品名称
    • Germany (DE)
      ESMOCARD LYO 2500 mg Pulver zur Herstellung einer Infusionslösung
    • United Kingdom (Northern Ireland) (XI)
      ESMOCARD LYO 2500 mg powder for solution for infusion
    • France (FR)
    • Italy (IT)
    • Greece (GR)
    • Czechia (CZ)
      Esmocard LYO
    • Slovakia (SK)
      ESMOCARD LYO
    • Slovenia (SI)
      Esmocard Lyo 2500 mg prašek za koncentrat za raztopino
许可日期2010/09/09
最近更新日期2024/01/26
药物ATC编码
    • C07AB09 esmolol
申请类型
  • TypeLevel1:Line Extension
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase